Search
Search Results
##search.searchResults.foundPlural##
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2104PDF: 868HTML: 354 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1626PDF: 1074HTML: 413 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2280PDF: 1004HTML: 2220 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
841PDF: 551HTML: 4026 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3805PDF: 1512HTML: 319 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3459PDF: 1318HTML: 2300Fi.1 Gritti.Rambaldi: 220 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7753PDF: 2460HTML: 2101Table 1.: 234Table 2.: 242Table 3.: 226Table 4.: 219 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2041PDF: 749HTML: 716Table1: patient's characteristics: 166Table 2: profile of each patient: 190 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2607PDF: 1196HTML: 151 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1122PDF: 565Suppl. Files: 135HTML: 379 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1817PDF: 1011HTML: 1824Tables: 189 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1101PDF: 1201Suppl. Files: 581HTML: 94 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
536PDF: 268HTML: 104 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4177Suppl. Files: 1195PDF: 1109Html: 246 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1922PDF: 1190HTML: 331 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
209PDF: 323Suppl. Files: 57HTML: 90 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2888PDF: 1039HTML: 5630 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2171PDF: 1341HTML: 3509 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2311PDF: 1005HTML: 4963 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1131PDF: 889HTML: 280 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4616PDF: 1964HTML: 18042 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4444PDF: 939HTML: 1357Table1: 193 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2545PDF: 974HTML: 2246 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2675PDF: 1653HTML: 2440Table1: 206 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
136PDF: 426HTML: 44 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2965PDF: 1398HTML: 3719Untitled: 205Untitled: 220Untitled: 193 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1534PDF: 911HTML: 373 -
WHAT ARE FUNGAL INFECTIONS?
4291PDF: 2447HTML: 27650de Pauw: 255 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2084PDF: 830HTML: 1099 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2029PDF: 1195HTML: 790 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12750PDF: 1704HTML: 4339Cover letter: 211Figure 1: 218 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2969PDF: 1368HTML: 165







